Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level

Status:
Completed

Trial end date:
2018-02-15

Target enrollment:

Participant gender:

This is a single-Center, randomized, double-Blind, placebo-controlled, multiple ascending-dose Phase I trail.

Phase 1

Atridia Pty Ltd.